Private market continues positive upward momentum in AprilForge Private Market Index outperforms public markets as core metrics remain solid.
Private market continues positive upward momentum in April
Trading
Data
Solutions
Insights
About
Osteal Therapeutics, founded in 2013, is a biopharmaceutical company that striving to develop novel musculoskeletal therapeutics with the goal of treating infections that affect orthopedic systems. The company has developed a treatment called VT-X7, which is for periprosthetic joint infection (PJI), a rare complication that can occur during joint replacement surgeries. The treatment aims to target affected tissues directly with antibiotics and is intended to be more effective than traditional PJI treatments. Osteal Therapeutics is headquartered in Dallas, Texas.
Osteal Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Osteal Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Osteal Therapeutics is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
